Biomedical mechanisms of blood stasis syndrome of coronary heart disease by systems biology approaches

Chinese Journal of Integrative Medicine

Volumn 20, Issue 3, 2014, Pages 163-169

  Wang, Jie ^a   Yu, Gui ^a  

^a INSTITUTE OF CHINESE MATERIA MEDICA   (China)

Author keywords

blood stasis syndrome; coronary heart disease; systems biology

Indexed keywords

ALBUMIN; FIBRINOGEN; FIBRONECTIN; HAPTOGLOBIN; HIGH DENSITY LIPOPROTEIN; INTERLEUKIN 8; PHOSPHOPROTEIN;

ACTIN FILAMENT; ANGIOCARDIOGRAPHY; BLOOD FLOW; BLOOD RHEOLOGY; BLOOD STASIS SYNDROME; BLOOD VESSEL INJURY; BLOOD VISCOSITY; BODY MASS; CARDIOVASCULAR RISK; CELL COMMUNICATION; CELL POPULATION; CEREBROVASCULAR ACCIDENT; CHINESE MEDICINE; CIRCULATION; DESORPTION; DNA MICROARRAY; DNA MODIFICATION; ECCHYMOSIS; EPIGENETICS; EXTRACELLULAR MATRIX; FOCAL ADHESION; GENE EXPRESSION; GENOMICS; GLYCOBIOLOGY; HEMAGGLUTINATION; HEMATOLOGIC DISEASE; HEMOSTASIS; HUMAN; HYPERGLYCEMIA; HYPERLIPIDEMIA; IMAGE ANALYSIS; IMMUNE RESPONSE; INFLAMMATION; IONIZATION; ISCHEMIC HEART DISEASE; LIPIDOMICS; LIVER CIRRHOSIS; MASS SPECTROMETRY; METABOLISM; METABOLOMICS; MICROCIRCULATION; NONHUMAN; PATHOGENESIS; PERCUTANEOUS CORONARY INTERVENTION; PETECHIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; RESTENOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; RNA EXTRACTION; SIGNAL TRANSDUCTION; SYSTEMS BIOLOGY; THROMBOCYTE DYSFUNCTION; TRANSCRIPTOMICS; TWO DIMENSIONAL ELECTROPHORESIS; VASCULAR ENDOTHELIUM;

CORONARY DISEASE; HUMANS; SYNDROME; SYSTEMS BIOLOGY;

EID: 84896548370     PISSN: 16720415     EISSN: 19930402     Source Type: Journal    
DOI: 10.1007/s11655-013-1461-3     Document Type: Review

References (31)

1. Nabel EG, Braunwald E. A tale of coronary artery disease and myocardial infarction. N Engl J Med 2012;366:54-63.
2. Wright RS, Anderson JL, Adams CD, Bridges CR, Casey DE Jr, Ettinger SM, et al. 2011 ACCF/AHA focused update incorporated into the ACC/AHA 2007 Guidelines for the Management of Patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in collaboration with the American Academy of Family Physicians, Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons. J Am Coll Cardiol 2011;57:e215-e367.
3. Fitzgerald R, Pirmohamed M. Aspirin resistance: effect of clinical, biochemical and genetic factors. Pharmacol Ther 2011;130:213-225.
4. Maningat P, Breslow JL. Needed: pragmatic clinical trials for statin-intolerant patients. N Engl J Med 2011;365:2250-2251.
5. Andréll P, Ekre O, Grip L, Währborg P, Albertsson P, Eliasson T, et al. Fatality, morbidity and quality of life in patients with refractory angina pectoris. Int J Cardiol 2011;147:377-382.
6. Li S, Zhang ZQ, Wu LJ, Zhang XG, Li YD, Wang YY. Understanding ZHENG in traditional Chinese medicine in the context of neuro-endocrine-immune network. IET Syst Biol 2007;1:51-60. (Pubitemid 46779218)
7. Ma T, Tan C, Zhang H, Wang M, Ding W, Li S. Bridging the gap between traditional Chinese medicine and systems biology: the connection of Cold Syndrome and NEI network. Mol Biosyst 2010;6:613-619.
8. Jiang WY. Therapeutic wisdom in traditional Chinese medicine: a perspective from modern science. Trends Pharmacol Sci 2005;26:558-563.
9. Evans WE, McLeod HL. Pharmacogenomics - drug disposition, drug targets, and side effects. N Engl J Med 2003;348:538-549. (Pubitemid 36159890)
10. Shang QH, Xu H, Lu XY, Wen C, Shi DZ, Chen KJ. A multi-center randomized double-blind placebo-controlled trial of Xiongshao Capsule in preventing restenosis after percutaneous coronary intervention: a subgroup analysis of senile patients. Chin J Integr Med 2011;17:669-674.
11. He QY, Wang J, Zhang YL, Tang YL, Chu FY, Xiong XJ. Effect of Yiqi Yangyin Decoction on the quality of life of patients with unstable angina pectoris. Chin J Integr Med 2010;16:13-18.
12. Wang J, He QY, Zhang YL. Effect of Shenshao Tablet on the quality of life for coronary heart disease patients with stable angina pectoris. Chin J Integr Med 2009;15:328-332.
13. Gao ZY, Xu H, Shi DZ, Wen C, Liu BY. Analysis on outcome of 5,284 patients with coronary artery disease: The role of integrative medicine. J Ethnopharmacol 2012;141:578-583.
14. Wang J, Chen KJ, Weng WL, Qian ZH, Wang Y, Liu JG, et al. Study on the diagnostic criteria of blood stasis syndrome. Chin J Integr Tradit West Med (Chin) 1988;8:585-587,589.
15. Xu H, Lu XY, Chen KJ. Study on correlation of bloodstasis syndrome and its accompanied syndromes with pathological changes showed in coronary angiography and restenosis after percutaneous coronary intervention. Chin J Integr Tradit West Med (Chin) 2007;27:8-13.
16. Xu H, Shi DZ, Chen KJ. Clinical effect of Xiongshao capsule on preventing restenosis post-PTCA or/and stenting. Chin J Integr Tradit West Med (Chin) 2000;20:494-497.
17. Yang BL, Wang J, Yang J. General situation of study on blood stasis syndrome of coronary heart disease. Chin J Inf Tradit Chin Med (Chin) 2003;10:86-87.
18. Ideker T, Galitski T, Hood L. A new approach to decoding life: systems biology. Annu Rev Genomics Hum Genet 2001;2:343-372. (Pubitemid 35265011)
19. Buriani A, Garcia-Bermejo ML, Bosisio E, Xu Q, Li H, Dong X, et al. Omic techniques in systems biology approaches to traditional Chinese medicine research: present and future. J Ethnopharmacol 2012;140:535-544.
20. Gomase VS, Tagore S. Transcriptomics. Curr Drug Metab 2008;9:245-249. (Pubitemid 351843592)
21. Freedman JE, Larson MG, Tanriverdi K, O'Donnell CJ, Morin K, Hakanson AS, et al. Relation of platelet and leukocyte inflammatory transcripts to body mass index in the Framingham heart study. Circulation 2010;122:119-129.
22. Ma XJ, Yin HJ, Chen KJ. Differential gene expression profiles in coronary heart disease patients of blood stasis syndrome in traditional Chinese medicine and clinical role of target gene. Chin J Integr Med 2009;15:101-106.
23. Yang J, Wang MQ, Li WH. Correlation between blood stasis syndrome of the coronary heart disease and the abnormal expression of actin-related genes. J Tradit Chin Med (Chin) 2009;50:538-540.
24. Cox J, Mann M. Is proteomics the new genomics? Cell 2007;130:395-398. (Pubitemid 47198310)
25. Vaisar T, Mayer P, Nilsson E, Zhao XQ, Knopp R, Prazen BJ. HDL in humans with cardiovascular disease exhibits a proteomic signature. Clin Chim Acta 2010;411:972-979.
26. Wu HJ, Ma ZC, Gao Y, Wang SQ. Study on GAP in bloodstasis type of coronary heart disease by using proteomic technique. Chin J Integr Med Cardio-/Cerebrovascular Dis (Chin) 2005;3:189-191.
27. Zhao HH, Wang W, Wang SR, Guo SZ, Li H. Study on unstable angina blood-stasis syndrome by two-dimensiona electrophoresis and matrix-assisted laser desorption/Ionization time of flying mass spectrometry. Chin Archives Tradit Chin Med (Chin) 2008;26:724-726.
28. Li XF, Jiang YR, Gao ZY. Screening, identification and analysis of platelet differential functional proteins in patients with coronary heart disease of blood-stasis pattern. Chin J Integr Tradit West Med (Chin) 2010;30:467-473.
29. Barton RH. A decade of advances in metabonomics. Expert Opin Drug Metab Toxicol 2011;7:129-136.
30. Yan B, A J, Hao H, Wang G, Zhu X, Zha W, et al. Metabonomic phenotype and identification of "heart blood stasis obstruction pattern" and "qi and yin deficiency pattern" of myocardial ischemia rat models. Sci China C Life Sci 2009;52:1081-1090.
31. Duncan H. An update on the clinical laboratory improvement amendments of 1988. Lab Medicine 2008;39:69-72.